CAR T cells armed with IL-15 show promise in treating solid cancers
GPC3-CAR T cells armed with IL-15 were evaluated in the second patient cohorts that again included adults (NCT05103631) and ...
pharmaphorum2d
Ipsen doubles up in TCEs for cancer, adding Biomunex drug
In a statement, Ipsen said that GPC3 is a well-validated target in oncology and is highly expressed across several tumour types, including hepatocellular carcinoma (HCC). Meanwhile, MAIT cells are ...
Hosted on MSN4mon
Moderate expression of CD39 in GPC3-CAR-T cells shows high efficacy against hepatocellular carcinoma
More information: Fan Zou et al, Moderate expression of CD39 in GPC3-CAR-T cells shows high efficacy against hepatocellular carcinoma, Frontiers of Medicine (2024). DOI: 10.1007/s11684-024-1071-9 ...
The Manila Times16d
Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Income tax expense increased by $6.7 million in 2024 compared to 2023, primarily due to an increase in U.S. taxes under the Subpart F income rules and due to an increase in deferred income tax expense ...